866-997-4948(US-Canada Toll Free)

Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2018

Published By :

GlobalData

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 56 Pages

Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, Progressive Supranuclear Palsy Global Clinical Trials Review, H1, 2018" provides an overview of Progressive Supranuclear Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Progressive Supranuclear Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Progressive Supranuclear Palsy Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Source 56

List of Tables
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region, 2018* 6
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 12
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 13
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 16
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase, 2018* 17
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 18
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 21
Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 22
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 23
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 24
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 25

List of Figures
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 13
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 16
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2018* 17
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 18
Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 21
Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 22
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 23
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 24
Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 25
GlobalData Methodology 55

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *